Company: BIAF
Filing Date: 2025-05-05
Form Type: S-1/A
Source: 0001641172-25-008629
Chunk: 17

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-05
Form: S-1/A
Chunk 17
---
 |

| ● | We                                                        
 do not expect to pay dividends in the foreseeable future. |

| ● | Our                                                                                        
 Common Stock market price may never exceed the exercise price of our outstanding warrants. |

| ● | Holders                                                                            
 of our warrants have no rights as stockholders until they exercise their warrants. |

| ● | The                                                                                     
 provisions of our outstanding warrants could limit a warrant holder’s ability to choose 
 the judicial forum for disputes.                                                        |

| ● | The                                                                                              
 financial and operational projections that we may make from time to time are subject to inherent 
 risks.                                                                                           |

| ● | Our                                                                                        
 stock price has fluctuated in the past, has recently been volatile, and may be volatile in 
 the future.                                                                                |

| ● | Our                                        
 Common Stock has often been thinly traded. |

| ● | An                                                      
 investment in our Company may involve tax implications. |

| ● | Our                                                                                      
 ability to use our net operating loss carryforwards and certain other tax attributes may 
 be limited.                                                                              |

| ● | Our                                                                          
 Board can designate classes of Preferred Stock without stockholder approval. |

| ● | Provisions                                                                                 
 in our corporate charter documents and under Delaware law could make an acquisition of the 
 Company more difficult.                                                                    |

| ● | Provisions                                                                  
 in our Charter and Amended and Restated (“A&R”) Bylaws could make a merger, 
 tender offer, or proxy contest difficult.                                   |

| ● | Certain                                                                          
 provisions of Delaware’s General Corporation Law (“DGCL”) may have anti-takeover 
 effects.                                                                         |

| ● | Our                                                                                      
 Charter designates Delaware state or federal courts as the exclusive forum for disputes. |

| ● | Provisions                                                                                
 in our Charter and A&R Bylaws may discourage stockholders from bringing a lawsuit against 
 our directors and officers.                                                               |

| ● | Our                                                                        
 management collectively owns a substantial percentage of our Common Stock. |

| ● | If                                                                                         
 analysts publish unfavorable research, or none at all, about our business, our stock price 
 and trading volume could decline.                                                          |

| ● | Any                                                                                               
 inability to report and file our financial results accurately and timely could harm our business. |

| 4 |

<div align='center'>THE OFFERING</div>

The following summary contains basic information about this offering. The summary is not intended to be complete. You should read the full text and more specific details contained elsewhere in this prospectus.

| Common                                             
 Stock Offered                                      |